Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Dean

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Biochemical Pharmacology|February 23, 1996
Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotidesA J Stewart, Y Canitrot, E Baracchini, et al.
The Journal of Biological Chemistry|May 2, 2001
Identification of an estrogen-inducible phosphatase (PP5) that converts MCF-7 human breast carcinoma cells into an estrogen-independent phenotype when expressed constitutivelyG Urban, T Golden, I V Aragon, et al.
Biochemical Society Transactions|August 1, 1996
Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agentsN M Dean, R McKay, L Miraglia, et al.
Molecular and Cellular Biology|February 12, 2000
Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent mannerO Potapova, M Gorospe, R H Dougherty, et al.
The Journal of Biological Chemistry|May 29, 2000
c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cellsO Potapova, M Gorospe, F Bost, et al.
Biochemical Society Transactions|August 1, 1996
Second-generation antisense oligonucleotides: structure-activity relationships and the design of improved signal-transduction inhibitorsK H Altmann, D Fabbro, N M Dean, et al.
The Journal of Biological Chemistry|January 9, 1999
Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expressionR A McKay, L J Miraglia, L L Cummins, et al.
Cancer Letters|July 4, 1998
Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alphaJ U Dennis, N M Dean, C F Bennett, et al.
Science (New York, N.Y.)|June 29, 1990
PDGF-induced activation of phospholipase C is not required for induction of DNA synthesisT D Hill, N M Dean, L J Mordan, et al.
Molecular and Cellular Biology|August 25, 2000
5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cellsV Taylor, M Wong, C Brandts, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Biochemical Pharmacology|February 23, 1996
Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotidesA J Stewart, Y Canitrot, E Baracchini, et al.
The Journal of Biological Chemistry|May 2, 2001
Identification of an estrogen-inducible phosphatase (PP5) that converts MCF-7 human breast carcinoma cells into an estrogen-independent phenotype when expressed constitutivelyG Urban, T Golden, I V Aragon, et al.
Biochemical Society Transactions|August 1, 1996
Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agentsN M Dean, R McKay, L Miraglia, et al.
Molecular and Cellular Biology|February 12, 2000
Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent mannerO Potapova, M Gorospe, R H Dougherty, et al.
The Journal of Biological Chemistry|May 29, 2000
c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cellsO Potapova, M Gorospe, F Bost, et al.
Biochemical Society Transactions|August 1, 1996
Second-generation antisense oligonucleotides: structure-activity relationships and the design of improved signal-transduction inhibitorsK H Altmann, D Fabbro, N M Dean, et al.
The Journal of Biological Chemistry|January 9, 1999
Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expressionR A McKay, L J Miraglia, L L Cummins, et al.
Cancer Letters|July 4, 1998
Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alphaJ U Dennis, N M Dean, C F Bennett, et al.
Science (New York, N.Y.)|June 29, 1990
PDGF-induced activation of phospholipase C is not required for induction of DNA synthesisT D Hill, N M Dean, L J Mordan, et al.
Molecular and Cellular Biology|August 25, 2000
5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cellsV Taylor, M Wong, C Brandts, et al.
Pageof 8